Cvs Health (CVS) Share-based Compensation (2009 - 2026)

Cvs Health (CVS) has reported Share-based Compensation for 18 consecutive years, with -$876.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 563.64% year-over-year to -$876.0 million; the trailing twelve-month figure through Jun 2026 stood at $269.0 million (up 136.75% YoY), and the FY2025 full-year result was $2.6 billion, up 380.19% from the prior year.
• Share-based Compensation slipped to -$876.0 million in Q2 2026 per CVS's latest filing, from -$479.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $2.8 billion in Q1 2024 and bottomed at -$1.4 billion in Q3 2024.
• Historically, Share-based Compensation has averaged $158.7 million across 5 years, with a median of -$75.5 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Share-based Compensation tumbled 3391.67% in 2023, then surged 746.77% in 2025.
• Over 5 years, Share-based Compensation stood at $150.0 million in 2022, then tumbled by 53.33% to $70.0 million in 2023, then tumbled by 542.86% to -$310.0 million in 2024, then surged by 746.77% to $2.0 billion in 2025, then plunged by 143.69% to -$876.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered -$876.0 million, -$479.0 million, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.